Sign up for this email series:
“Caregiving is a marathon, it’s not a sprint … so changing the focus to yourself is necessary to maintain your health as a healthy caregiver.”
That was one key piece of advice that Dr. Jennifer Davis shared during myALZteam’s live Q&A on March 23, 2021, hosted by myALZteam co-founder Mary Ray.
Dr. Davis answered members’ questions about whether dementia is hereditary, the age when the risk for getting Alzheimer’s disease rises, and how to maintain strong brain health.
Members submitted scores of questions leading up to and during the event, with many myALZteam members curious about whether any upcoming treatments are on the horizon that will help treat Alzheimer’s disease.
Here are some of the things Dr. Davis discussed during the live Q&A:
Check out the video to see the entire one-hour discussion, and register to be notified about future upcoming live events on myALZteam.
Disclaimer: The information, including but not limited to, information from presenters, text, graphics, images, and other material shared during this event is for informational purposes only. The information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you heard during this event.
Dr. Jennifer Duncan Davis is a clinical neuropsychologist specializing in Alzheimer's disease and related disorders, movement disorders, epilepsy, and general medical neuropsychology. She completed her bachelor's degree in biopsychology at Bates College and her Ph.D. in clinical psychology (with a neuropsychology specialization) at the University of Utah. She came to Brown University in 2000 to complete her predoctoral internship in neuropsychology and remained as a clinical fellow in adult general medical neuropsychology at Rhode Island Hospital (RIH). After completing her clinical fellowship, she joined the neuropsychology staff in the department of psychiatry at RIH and remained at Brown as a Dementia T32 fellow to continue her research training in aging and dementia. Her primary areas of research are in mild cognitive impairment and Alzheimer's disease, including driving safety in individuals with early Alzheimer's disease, psychosocial interventions to improve cognition and quality of life in individuals with Alzheimer's disease, and dementia caregiver interventions.
Mary Ray, co-founder and COO of MyHealthTeams, has a deep understanding of consumer behavior and social networking, which has made the company’s mobile and web apps a daily habit for millions facing a chronic health condition. Her innovative vision for digital health solutions has transformed the way people connect with others who share their diagnosis, facilitating unfiltered conversation and accelerating access to trusted information. Recognized for building scalable platforms that drive consumer engagement, Mary was honored as a DTC Innovator and a PM360 ELITE in 2019. She has contributed to Forbes and been quoted in industry publications at the intersection of health and technology. She has spoken at conferences including the DTC Forum on Social Media and Technology, Health Datapalooza and Digital Pharma. Mary is an advocate for women in technology and has served as a SXSW mentor and a speaker at the Stanford Graduate School of Business. She is a graduate of the College of William & Mary School of Business and George Mason University.